top of page

Publications

The use of non-thermal plasma for DNA decontamination in a forensic Vacuum Metal Deposition chamber: A proof of concept study (2025).

Hussain K, King RSP, Allan RN, Farrugia K, Krzeminska-Ahmadzai U.

Forensic Science International.

PMID: 40163931

DOI: 10.1016/j.forsciint.2025.112453

[Article Link]

Unravelling the atomistic mechanism of electrostatic lateral association of peptide b-sheet structures and its role in nanofibre growth and hydrogelation (2025).

Soliman MAN, Khedr A, Sahota T, Armitage R, Allan RN, Laird K, Allcock N, Alazragi R, Edwards-Gayle CJC, Wychowaniec JK, Vargiu AV, Elsawy MA.

Small.

PMID: 39780584

DOI: 10.1002/smll.202408213

[Article Link]

Multi-excitation Raman spectroscopy for label-free, strain-level characterisation of bacterial pathogens in artificial sputum media (2022).

Lister AP, Highmore CJ, Hanrahan N, Read J, Munro APS, Tan S, Allan RN, Faust SN, Webb JS, Mahajan S.

Analytical Chemistry.

PMID: 34978813

DOI: 10.1021/acs.analchem.1c02501

[Article Link]

Staphylococcus aureus internalisation enhances bacterial survival through modulation of host immune responses and mast cell activation (2020).

Biggs TC, Abadalkareem RS, Hayes SM, Holding RE, Lau LC, Harries PG, Allan RN, Pender SLF, Walls AF, Salib RJ.

Allergy.

PMID: 33314209

DOI: 10.1111/all.14701

[Article Link]

An integrated model system to gain mechanistic insights into biofilm-associated antimicrobial resistance in Pseudomonas aeruginosa MPAO1 (2020).

Allan RN*, Varadarajan AR*, Valentin JDP*, Castaneda Ocampo OE, Somerville V, Pietsch F, Buhmann MT, West J, Skipp PJ, van der Mei HC, Ren Q, Schreiber F, Webb JS, Aherns CH.

npj Biofilms and Microbiomes.

PMID: 33127897

DOI: 10.1038/s41522-020-00154-8

[Article Link] *Equal contribution

Antimicrobial activity of the quinolone derivative HT61 against Staphylococcus aureus biofilms (2020).

Frapwell CJ, Skipp PJ, Howlin RP, Angus EM, Hu Y, Coates, ARM, Webb JS*, Allan RN*

Antimicrobial Agents and Chemotherapy.

PMID: 32122902

DOI: 10.1128/AAC.02073-19

[Article Link] *Equal contribution

Editorial: Polymicrobial biofilms in chronic infectious disease (2020).

Harrison F, Allan RN, Maddocks SE.

Frontiers in Cellular and Infection Microbiology.

PMID: 33425788

DOI: 10.3389/fcimb.2020.628584

[Article Link]

Staphylococcus aureus internalisation in mast cells in nasal polyps - characterisation of interactions and potential mechanisms (2020).

Hayes SM, Biggs TC, Goldie SP, Harries PG, Walls AF, Allan RN, Pender SLF, Salib RJ.

Journal of Allergy and Clinical Immunology.

PMID: 31254531

DOI: 10.1016/j.jaci.2019.06.013

[Article Link]

Cephalosporin nitric oxide-donor prodrug DEA-3CD disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa (2019).

Soren O, Rineh A, Silva DG, Cai Y, Howlin RP, Allan RN, Feelisch M, Davies JC, Connett GJ, Faust SN, Kelso MJ, Webb JS.

Journal of Antimicrobial Chemotherapy.

PMID: 31682251

DOI: 10.1093/jac/dkz378 

[Article Link]

Immunological profiling of key inflammatory drivers of nasal polyp formation and growth in chronic rhinosinusitis (2019).

Biggs TC, Hayes SM, Harries PG, Allan RN, Walls AF, Pender SLF, Salib RJ.

Rhinology.

PMID: 31317972

DOI: 10.4193/Rhin19.167

[Article Link]

Evaluation of a bio-engineered honey and its synthetic equivalent as novel Staphylococcus aureus biofilm-targeted topical therapies in chronic rhinosinusitis (2019).

Papadopoulou D, Dabrowska A, Harries PG, Webb JS, Allan RN, Salib RJ.

American Journal of Rhinology and Allergy.

PMID: 31510757

DOI: 10.1177/1945892419874700

[Article Link]

Increased rates of genomic mutation in a biofilm co-culture model of P. aeruginosa and S. aureus (2018).

Frapwell CJ, Howlin RP, Soren O, McDonagh BT, Duignan CM, Allan RN, Horswill AR, Stoodley P, Hu Y, Coates ARM, Webb JS.

BioRxiv.

DOI: 10.1101/387233

[Article Link]

Antimicrobial activity of a novel bioengineered honey against non-typeable Haemophilus influenzae biofilms: an in vitro study (2018).

Newby RS, Dryden M, Salib RJ*, Allan RN*.

Journal of Clinical Pathology.

PMID: 29449345

DOI: 10.1136/jclinpath-2017-204901

[Article Link] *Equal contribution

Targeting Biofilms: Current and Prospective Therapeutics (2017).

Allan RN*, Koo H, Howlin RP, Stoodley P & Hall-Stoodley L.

Nature Reviews Microbiology.

PMID: 28944770

DOI: 10.1038/nrmicro.2017.99

[Article Link]

Cephalosporin-3’-diazeniumdiolate NO-donor prodrug PYRRO-C3D enhances azithromycin susceptibility of non-typeable Haemophilus influenzae biofilms (2017).

Collins SA, Kelso MJ, Rineh A, Yepuri NR, Coles J, Jackson CL, Halladay GD, Walker WT, Webb JS, Hall-Stoodley L, Connett, G, Feelisch M, Faust SN, Lucas JSA & Allan RN.Antimicrobial Agents and Chemotherapy.

PMID: 27919896

DOI: 10.1128/AAC.02086-16

[Article Link]

Primary ciliary dyskinesia ciliated airway cells show increased susceptibility to Haemophilus influenzae biofilm formation (2017).

Walker WT, Jackson C, Allan RN, Collins SA, Kelso MJ, Rineh A, Yepuri NR, Nicholls B, Lau L, Johnstone D, Lackie P, Faust SN, Lucas JSA & Hall-Stoodley L.

European Respiratory Journal.

PMID: 28890436

DOI: 10.1183/13993003.00612-2017

[Article Link]

D-methionine interferes with non-typeable Haemophilus influenzae peptidoglycan synthesis during growth and biofilm formation (2017).

Dawe H, Berger E, Sihlbom C, Angus EM, Howlin RP, Laver JR, Tebruegge M, Hall-Stoodley L, Stoodley P, Faust SN & Allan RN.

Microbiology.

PMID: 28699879

DOI: 10.1099/mic.0.000491

[Article Link]

Corticosteroids and infliximab impair the performance of interferon-gamma release assays used for tuberculosis screening (2017).

Edwards AE, Yifang G, Allan RN, Ball D, de Graaf H, Coelho V, Curtis N, Williams A, Faust SN, Marshall B, Elkington P & Tebruegge M.

Thorax.

PMID: 28159773

DOI: 10.1136/thoraxjnl-2016-209397

[Article Link]

Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis (2017).

Howlin R, Cathie K, Hall-Stoodley L, Cornelius V, Duignan C, Allan RN, Fernandez BO, Barraud N, Bruce KD, Jefferies J, Kelso M, Kjelleberg S, Rice SA, Rogers GB, Pink S, Smith C, Sukhtankar PS, Salib R, Legg J, Carroll M, Daniels T, Feelisch M, Stoodley P, Clarke SC, Connett G, Faust SN & Webb JS .

Molecular Therapy.

PMID: 28750737

DOI: 10.1016/j.ymthe.2017.06.021

[Article Link]

Cephalosporin-3’-diazeniumdiolate NO-donor prodrug PYRRO-C3D is active against Streptococcus pneumoniae biofilms despite the absence of b-lactamases (2017).

Allan RN, Kelso MJ, Rineh A, Yepuri NR, Feelisch M, Soren O, Brito-Mutunayagam S, Salib RJ, Stoodley P, Clarke SC, Webb JS, Hall-Stoodley L & Faust SN.

Nitric Oxide.

PMID: 28235635

DOI: 10.1016/j.niox.2017.02.006 

[Article Link]

Reactive Oxygen: a novel antimicrobial mechanism for targeting biofilm-associated infection (2017).

Dryden M, Cooke J, Holding RE, Biggs T, Salamat AA, Allan RN, Salib RJ, Newby RS, Halstead F, Oppenheim B, Hall T, Cox SC, Staples IL, Grover LM, Al-hindi Z, Novak-Frazer L & Richardson, MD.

Journal of Global Antimicrobial Resistance.

PMID: 28213334

DOI: 10.1016/j.jgar.2016.12.006 

[Article Link]

Low concentrations of nitric oxide modulate Streptococcus pneumoniae biofilm metabolism and antibiotic tolerance (2016).

Allan RN, Morgan S, Brito-Mutunayagam S, Skipp P, Feelisch M, Hayes SM, Hellier, W, Clarke SC, Stoodley P, Burgess A, Ismail-Koch H, Salib RJ, Webb JS, Faust SN & Hall-Stoodley L.

Antimicrobial Agents and Chemotherapy.

PMID: 26856845

DOI: 10.1128/AAC.02432-15

[Article Link]

Parallel evolution in Streptococcus pneumoniae biofilms (2016).

Churton NWV, Mirsa R, Howlin RP, Allan RN, Gharbia SE, Edwards RJ, Clarke SC & Webb JS.

Genome Biology and Evolution.

PMID: 27190203

DOI: 10.1093/gbe/evw072

[Article Link]

Environmental temperature impacts on the performance of QuantiFERON-TB Gold In-Tube assays (2015).

Jarvis J, Gao Y, de Graaf H, Hughes S, Allan RN, Williams A, Marshall B, Elkington P, Faust SN & Tebruegge M.

The Journal of Infection.

PMID: 25869537

DOI: 10.1016/j.jinf.2015.04.004

[Article Link]

Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome (2015).

Tebruegge M, Jones C, de Graaf H, Sukhtankar P, Allan RN, Howlin RP, Browning D, Schuster H, Pallett A, Patel S & Faust SN.

European Journal of Clinical Microbiology & Infectious Diseases.

PMID: 25326276

DOI: 10.1007/s10096-014-2256-y

[Article Link]

New approaches to the treatment of biofilm-related infections (2014).

Wilkins M, Hall-Stoodley L, Allan RN & Faust SN.

The Journal of Infection.

PMID: 25240819

DOI: 10.1016/j.jinf.2014.07.014 

[Article Link]

Pronounced metabolic changes in adaptation to biofilm growth by Streptococcus pneumoniae (2014).

Allan RN, Skipp P, Jefferies J, Clarke SC, Faust SN, Hall-Stoodley L & Webb J.

PLoS One.

PMID: 25188255

DOI: 10.1371/journal.pone.0107015

[Article Link]

Effect of amino-acid substitutions in the GerAA protein on the function of the alanine-responsive germinant receptor of Bacillus subtilis spores (2011).

TMongkolthanaruk W, Cooper G, Mawer J, Allan RN & Moir A.

Journal of Bacteriology.

PMID: 21378197

DOI: 10.1128/JB.01398-10 

[Article Link]

Aerobic, endospore-forming bacteria from Antarctic geothermal soils (2008).

Logan NA & Allan RN.

Microbiology of Extreme Soils.

DOI: 110.1007/978-3-540-74231-9_8

[Article Link]

Brevibacillus levickii sp. nov. and Aneurinibacillus terranovensis sp. nov., two thermoacidophiles isolated from geothermal soils of northern Victoria Land, Antarctica (2005).

Allan RN, Lebbe L, Heyrman J, De Vos P, Buchanan CJ & Logan NA.

International Journal of Systematic & Evolutionary Microbiology.

PMID: 15879231

DOI: 110.1099/ijs.0.63397-0

[Article Link]

bottom of page